Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● Its low valuation, with P/E ratio at 4.59 and 4.7 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The stock, which is currently worth 2022 to 0.31 times its sales, is clearly overvalued in comparison with peers.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● This company will be of major interest to investors in search of a high dividend stock.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● The company's earnings growth outlook lacks momentum and is a weakness.

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Over the past twelve months, analysts' opinions have been revised negatively.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.